Latest filing published 06 Aug 2020 for Prestige Consumer Healthcare Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of James M. Jenness across 2 companies, led by Kellanova and Prestige Consumer Healthcare Inc. Over a trading history stretching from 8 August 2005 to 4 August 2020, the count stands at 95 filings.
On the open market, the record shows 3 purchases worth €478k and 18 sales worth €47.5M. Taken together, the sales exceed the purchases by €47.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 43 share grants and 31 option exercises.
Half of the purchases are above €120k and half below.
The newest entry dates from 6 August 2020: a share grant, in Prestige Consumer Healthcare Inc. The clock since the last published purchase (6 February 2018) now reads 3,181 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 95 declarations